Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Myomo Second Quarter 2021 Financial Results Feature Significant Increases in Revenue and Gross Margin, Record Insurance Authorizations and Orders

Myomo (MYO) Tops Q2 EPS by 14c

August 9, 2021 4:39 PM EDT

Myomo (NYSE: MYO) reported Q2 EPS of ($0.46), $0.14 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $2.1 million.

We are pleased to be reporting sustained momentum with our efforts to expand the number of individuals who receive a MyoPro through our direct-to-consumer marketing and our own clinical services channel,... More